A groundbreaking study published in the American Journal of Medical Quality reveals that healthcare providers increasingly leverage syndromic PCR-based molecular tests to guide antibiotic therapy and ...

Market OverviewThe global Molecular Diagnostics Market is valued at USD 14.9 Billion in 2022 and is projected to reach a ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust ...

OSANG Healthcare partners with KAIST, NANO to develop PCR tests for STIs Innovative partnership aims to enhance diagnostic ...

The CSIC-UNESPA scientific expedition has been underway since last January with the aim of monitoring the presence of the ...

Application segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 8%. The AISS (Clinical) Application ...

As the incidence of genetic disorders increases, there is a corresponding rise in the demand for molecular biology enzymes, kits, and reagents essential for conducting tests. These tools are vital for ...

Mycoplasma contamination often comes from infected cultures shared between research labs. It can also sneak in through cell culture media and animal products used in cell culture. Even the lab team ...

The deal will let ABL commercialize tests equivalent to those that had been offered by the shuttered Siemens subsidiary Fast Track Diagnostics.

Mechelen, Belgium Monday, February 17, 2025, 16:00 Hrs [IST] ...